Familial hypercholesterolaemia (FH) is an autosomal dominant disorder caused by functional mutations in LDLR (>90%), APOB (5-10%) and PCSK9 (1-3%). An accurate genetic diagnosis is essential for a correct diagnosis. However it is known that only a small part of the variants identified have been characterized by in vitro functional assays. To overcome this lack of functional data the American College of Medical Genetics and Genomics (ACMG) published recently a guideline for variant interpretation in clinical settings. The propose of this review was to analyze the number of total variants in LDLR associated with FH worldwide and classify these variants’ pathogenicity by the application of ACMG variant interpretation guidelines with a specia...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
PURPOSE: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder of lipid metabol...
Familial hypercholesterolaemia (FH) is an autosomal dominant disorder of lipid metabolism presenting...
PurposeFamilial hypercholesterolemia (FH) is an autosomal disorder of lipid metabolism presenting wi...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by high blood-cho...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by high blood-cho...
Familial Hypercholesterolemia (FH) is a genetic autosomal dominant disorder characterized clinically...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Familial Hypercholesterolemia (FH) is one of the most frequent dyslipidemias, the autosomal dominant...
Familial Hypercholesterolemia (FH) is one of the most frequent dyslipidemias, the autosomal dominant...
Background: The lack of functional evidence for most variants detected during the molecular screenin...
The online version of this article (https://doi.org/10.1016/j. gim.2021.09.012) contains supplement...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
PURPOSE: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder of lipid metabol...
Familial hypercholesterolaemia (FH) is an autosomal dominant disorder of lipid metabolism presenting...
PurposeFamilial hypercholesterolemia (FH) is an autosomal disorder of lipid metabolism presenting wi...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by high blood-cho...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by high blood-cho...
Familial Hypercholesterolemia (FH) is a genetic autosomal dominant disorder characterized clinically...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Familial Hypercholesterolemia (FH) is one of the most frequent dyslipidemias, the autosomal dominant...
Familial Hypercholesterolemia (FH) is one of the most frequent dyslipidemias, the autosomal dominant...
Background: The lack of functional evidence for most variants detected during the molecular screenin...
The online version of this article (https://doi.org/10.1016/j. gim.2021.09.012) contains supplement...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
PURPOSE OF REVIEW: To present up to date evidence on the pathogenicity of low-density lipoprotein r...
PURPOSE: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder of lipid metabol...